ARTICLE | Company News
Cerep, Sepracor in R&D deal
October 29, 2001 8:00 AM UTC
SEPR will use BioPrint technology from Cerep (NM:Cerep) to identify and discover drug candidates. BioPrint technology includes in vitro and in vivo data on the properties of 2,000 marketed compounds. ...